These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36789890)

  • 1. Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in Australia.
    Schofield D; Lee E; Parmar J; Kelly S; Hobbs M; Laing N; Mumford J; Shrestha R
    Genet Med; 2023 May; 25(5):100813. PubMed ID: 36789890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen.
    Beauchamp KA; Johansen Taber KA; Muzzey D
    Genet Med; 2019 Sep; 21(9):1948-1957. PubMed ID: 30760891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
    Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
    Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
    Norman R; van Gool K; Hall J; Delatycki M; Massie J
    J Cyst Fibros; 2012 Jul; 11(4):281-7. PubMed ID: 22425241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflex single-gene non-invasive prenatal testing is associated with markedly better detection of fetuses affected with single-gene recessive disorders at lower cost.
    Riku S; Hedriana H; Carozza JA; Hoskovec J
    J Med Econ; 2022; 25(1):403-411. PubMed ID: 35289246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for cystic fibrosis carriers: an economic evaluation.
    Rowley PT; Loader S; Kaplan RM
    Am J Hum Genet; 1998 Oct; 63(4):1160-74. PubMed ID: 9758600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening.
    Avram CM; Dyer AL; Shaffer BL; Caughey AB
    Prenat Diagn; 2021 Oct; 41(11):1449-1459. PubMed ID: 34346064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles.
    Lee M; Lofgren KT; Thomas A; Lanes A; Goldman R; Ginsburg ES; Hornstein MD
    Am J Obstet Gynecol; 2021 Jul; 225(1):55.e1-55.e17. PubMed ID: 33539823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology.
    Xi Y; Chen G; Lei C; Wu J; Zhang S; Xiao M; Zhang W; Zhang Y; Sun X
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1340. PubMed ID: 32573981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of prenatal screening for spinal muscular atrophy.
    Little SE; Janakiraman V; Kaimal A; Musci T; Ecker J; Caughey AB
    Am J Obstet Gynecol; 2010 Mar; 202(3):253.e1-7. PubMed ID: 20207244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of reproductive carrier screening for preconception and pregnant couples for multiple genetic conditions: a systematic review and meta-analysis.
    Wang T; Kiss D; McFadden K; Byrnes J; Scuffham P; Delatycki MB; Downes M
    Expert Rev Mol Diagn; 2023 May; 23(5):419-429. PubMed ID: 37086152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
    Ademi Z; Norman R; Pang J; Liew D; Zoungas S; Sijbrands E; Ference BA; Wiegman A; Watts GF
    Atherosclerosis; 2020 Jul; 304():1-8. PubMed ID: 32526542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of the Community Benefit of the Australian Pregnancy Register of Antiseizure Medications.
    Ademi Z; Marquina C; Perucca P; Hitchcock A; Graham J; Eadie MJ; Liew D; O'Brien TJ; Vajda FJ
    Neurology; 2023 Mar; 100(10):e1028-e1037. PubMed ID: 36460471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.